Studies using dual-energy X-ray absorptiometry (DEXA) scans show that approximately 25% of the total weight lost on tirzepatide consists of lean body mass
For example, tau, a pathological hallmark of Alzheimers disease, was observed to successfully degraded in human neurons [179]
How to switch from Wegovy to Zepbound Potential risks and considerations Switching from Wegovy to Zepbound may be associated with these potential risks: You may experience gastrointestinal issues because Zepound has an increased risk of gastrointestinal problems due to its dual mechanism of action Incorrect conversions can cause severe side effects such as hypoglycemia, gallbladder issues, and pancreatitis (inflammation of the pancreas) GLP-1 medications including Zepbound and Wegovy are not recommended during pregnancy, when planning to become pregnant, and when breastfeeding You may experience temporary fluctuations in weight and blood sugar levels Your healthcare insurance company may require a new prior authorization when switching medications or dosages If you experience severe side effects such as allergic reactions or glycemic coma due to incorrect dosage, immediately seek medical attention from a nearby medical facility Tips for a safe and smooth transition Keep a journal or tracking app to mention your medication dosages and any side effects you experience
We provide complete training so you feel confident and comfortable
Transcranial magnetic stimulation for stimulant use disorder (STIMULUS): Study protocol for a randomized controlled trial
If you are pregnant, an athlete or have concerns, please speak to a clinician
